Уноси

• Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2022)

  J. Kowalska, D. Bursa, D. Jilich, S. Antoniak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, L. Fleishhans, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, A. Skrzat-Klapaczyńska, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, 2022

• The case series of 34 patients with COVID-19 diagnosed with HIV infection from Central and Eastern European Countries - Euroguidelines in Central and Eastern Europe Network Group data (2020-09)

  K. Kase, A. Skrzat-Klapaczyńska, A. Vassilenko, A. Harxhi, B. Lakatos, G. Dragović-Lukić, D. Jilich, A. Verhaz, N. Yancheva, F. Dumitrescu, D. Jilih, L. Machala, A. Skrzat-Klapaczyńska, R. Matulionyte, The case series of 34 patients with COVID-19 diagnosed with HIV infection from Central and Eastern European Countries - Euroguidelines in Central and Eastern Europe Network Group data, Pulmonology research and respiratory care, pp. medRxiv - free on line, Sep, 2020

• Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group (2020-10)

  T. Balayan, J. Begovac, A. Skrzat-Klapaczyńska, P. Bukovinova, I. Aho, I. Alexiev, D. Salemovic, D. Gokengin, T. Harxhi, Đ. Jevtovic, K. Kase, A. Verhaz, N. Yancheva, O. Yurin, A. Horban, J. Kowalska, Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group, HIV MEDICINE, Vol. 21, No. 9, pp. 1 - 6, Oct, 2020

• Viral hepatitis in HIV-positive patients - testing, prophylaxis and treatment in Central and Eastern Europe (2020-10)

  K. Kase, A. Skrzat-Klapaczyńska, R. Matulionyte, V. Mulabdic, P. Bukovinova, A. Vassilenko, N. Bolokadze, D. Jilih, A. Verhaz, D. Gokengin, G. Dragović-Lukić, A. Horban, Viral hepatitis in HIV-positive patients - testing, prophylaxis and treatment in Central and Eastern Europe, HIV MEDICINE, Vol. 20 (2019), No. Suppl.9;, pp. 270 - 271, Oct, 2020

• The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease – a report from Central and Eastern Europe (2020-12)

  J. Kowalska, K. Kase, A. Vassilenko, A. Harxhi, B. Lakatos, G. Dragović-Lukić, A. Verhaz, N. Yancheva, F. Dumitrescu, D. Jilich, L. Machala, A. Skrzat-Klapaczyńska, R. Matulionyte, The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease – a report from Central and Eastern Europe, INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, pp. 1 - 11, Dec, 2020

• Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19) (2021-12)

  B. Lakatos, J. Kowalska, S. Antoniak, D. Gokengin, J. Begovac, A. Vassilenko, p. wasilevski, l. fleischhans, D. Lakatos, R. Matulionyte, K. Kase, A. Papadopoulus, N. Rukhadze, A. Harxhi, S. Hofman, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, C. Oprea, Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19), HIV MEDICINE, Vol. 23, No. 1468-1293, pp. 1 - 8, Dec, 2021

• The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group (2022-05)

  J. Kowalska, C. Bienkowski, L. Fleishhans, S. Antoniak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Gokengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Jancheva, J. Begovac, A. Horban, The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group, STED Journal, Vol. 14, No. 5, pp. 1 - 12, May, 2022

• The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group (2022-06)

  A. Skrzat-Klapaczyńska, J. Kowalska, S. Antonyak, T. Balayan, J. Begovac, D. Bursa, G. Dragović-Lukić, D. Gokengin, L. Afonina, A. Harxhi, D. Jilich, K. Kase, A. Verhaz, B. Lakatos, M. Mardarescu, R. Matulionyte, A. Panteleev, A. Papadopoulus, L. Sojak, C. Oprea, J. Tomazic, A. Vassilenko, M. Vasyliev, A. Verhaz, N. Yancheva, O. Yurin, A. Horban, The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, Vol. 19 (13), No. 19(13), pp. 1 - 9, Jun, 2022

• Viral hepatitis in HIV-positive patients – testing, prophylaxis and treatment in Central and Eastern Europe (2019-11)

  K. Kase, A. Skrzat-Klapaczyńska, J. Kowalska, A. Verhaz, Viral hepatitis in HIV-positive patients – testing, prophylaxis and treatment in Central and Eastern Europe, EACS Conference 2019 Abstract Nr PE31/11, Nov, 2019

• Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2021-10)

  J. Kowalska, D. Bursa, D. Jilich, S. Antonjak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, A. Verhaz, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, ePoster. PE4/18ecee.president@gmail.com, Oct, 2021

• Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group (2022-07)

  J. Kowalska, M. Vasyliev, A. Harxhi, L. Fleischhans, S. Antoniak, D. Gokengin, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, B. Lakatos, G. Dragović-Lukić, D. Jilich, A. Verhaz, A. Verhaz, J. Begovac, A. Skrzat-Klapaczyńska, C. Oprea, Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group, Jul, 2022

• Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group (2022-11)

  J. Kowalska, C. Bieńkowski, L. Fleischhans, S. Antonjak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Goengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, . Horban, Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group, Nov, 2022